CASSELLA JAMES V (Chief Development Officer) sold 1.5% of their position (2.89K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $21.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/9/2023ACC: 0001209191-23-002551
Officer· Chief Development Officer
Since Jan 2019
-2.89K
Net shares
Net seller
$21.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.89K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.89K
Price / share
$7.25
Trade value
$20.97K
% of position
1.5%
1/6/2023
189.82K→186.93K
Total
Net shares
−2.89K
Net value
-$20.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2023 | S · Sale | −2.89K | $7.25 | $20.97K | 1.5% | 189.82K | 186.93K |
| Total | −2.89K | -$20.97K | ||||||
Derivative Transactions0
No derivative transactions reported